Status:
TERMINATED
DiagNostic Study of Low-dose CT and multipleX PCR on Antibiotic Treatment and Outcome of Community-Acquired Pneumonia
Lead Sponsor:
MJM Bonten
Collaborating Sponsors:
BioMérieux
Conditions:
Community-acquired Pneumonia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Rationale: Uncertainty in the clinical and etiological diagnosis of community-acquired pneumonia (CAP) often leads to incorrect treatment and unnecessary use of broad-spectrum antibiotics. Establishi...
Eligibility Criteria
Inclusion
- aged 18 years or above;
- working diagnosis of CAP at the emergency department with the presence of at least two clinical criteria or one clinical criterion and radiological evidence of CAP, with no other explanation for the signs and symptoms;
- requiring hospitalisation to a non-ICU ward via the ER.
Exclusion
- Hospitalisation for two or more days in the last 14 days;
- Residence in a long-term care facility in the last 14 days;
- History of cystic fibrosis;
- Severe immunodeficiency
Key Trial Info
Start Date :
November 27 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2021
Estimated Enrollment :
3555 Patients enrolled
Trial Details
Trial ID
NCT03360851
Start Date
November 27 2017
End Date
March 1 2021
Last Update
May 21 2021
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Noordwest Ziekenhuisgroep
Alkmaar, Netherlands
2
Amphia Ziekenhuis
Breda, Netherlands
3
Catharina Ziekenhuis
Eindhoven, Netherlands
4
Ter Gooi Ziekenhuis
Hilversum, Netherlands